VAV2 and cancer: Fludarabine can also inhibit ribonucleotide reductase activity and thus diminish the dATP pool and DNA synthesis.49,50 In light of these findings, one may expect that Fludarabine could be a potent sensitizer for radiotherapy of cancer with VAV2 overexpression.